2023

Veneno Technologies Co., Ltd. has been certified as an AISol Startup. For more information, please click here.

Veneno Technologies, a Novel DRP Drug Discovery Company, has entered into a joint research agreement with Sumitomo Pharma Co. Ltd. For more information, please click […]

Veneno Technologies, a Novel DRP Drug Discovery Company, has entered into a joint research agreement with Astellas Pharma Inc. For more information, please click here.

Veneno Technologies will exhibit at Blockbuster TOKYO Lifescience Startup career fair 2023. Blockbuster TOKYO Lifescience Startup career fair 2023

Veneno Technologies will participate in the Global life science pitch +mentorship event. Dr. Taira, Director, will be on stage on the day. Global life science […]

The 1st Veneno Technologies Seminar – Introduction to Environmentally Friendly Next Generation Peptide Pesticides – was held.During the seminar, three distinguished researchers presented various aspects […]

Veneno Technologies will participate in AIST Startup Pitch – Startup Alumni Association from AIST. Dr. Kimura, Director, will speak at the event. (CIC, Tokyo) Startup […]

Our company was interviewed and introduced by “JSTORIES”, a bilingual media that introduces new innovations by Japanese companies to the world.Entitled, From lethal poison to […]

Veneno Technologies will participate in the 11th DSANJ (Drug Seeds Alliance Network Japan) Digital Bio Conference 2023 hosted by AMED, Japan Pharmaceutical Manufacturers Association, and […]

Veneno Technologies will participate in Kansai Bio Business Matching 2022. On the day of the event, Dr. Matsukawa, Director, will make a pitch introducing our […]